Method Peptides · Research compound

PNC-27

$60.00
DOSE: 5 mg
≥99% purity
Third-party tested
Ships from the USA
Secure, discreet packaging
ShippingFree on orders $200+

$15 flat rate on orders under $200.

FulfillmentEstimated 2–5 business days

Tracking is provided when the order ships.

Review return policy →

Research reference

Compound overview

Product specifications, research context, and handling information.

PNC-27 5 mg

PNC-27 is a synthetic peptide derived from a p53-related sequence and linked to a membrane-residency segment.

Research examines membrane interactions, HDM2-associated binding, and selective cytotoxicity in experimental cancer-cell models.

Key Research Areas

  • HDM2-associated binding studies
  • Cancer-cell membrane models
  • Membrane-disruption assays
  • Cell-selectivity research

Mechanism of Interest

PNC-27 is studied for binding interactions involving HDM2 expressed at or near the membrane in certain experimental cell models. Proposed membrane-disruption activity remains model-dependent and should not be generalized beyond controlled laboratory systems.

Product Details

Format: Lyophilized material in vial format
Available Options: 5 mg per vial
Compound Class: Synthetic p53-derived research peptide
Compound: PNC-27
Storage: Follow the product label and lot-specific storage instructions. Prepared-sample storage depends on formulation and validated laboratory stability conditions.

Membrane-Interaction Research

PNC-27 research examines whether peptide binding and membrane localization produce different responses across cell lines. Appropriate controls are required to evaluate selectivity, membrane integrity, and off-target effects.

Research Use Only:

This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.